Research ExplorerScientific StaffAnnette Lebeau Publications

PD.Dr.med. ID: 66340

Annette Lebeau

graph of relations
Affiliations
1 - 48 out of 48Page size: 50

Publications

  1. 2018

  2. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

    Wöckel, A., Festl, J., Stüber, T., Brust, K., Krockenberger, M., Heuschmann, P. U., Jírů-Hillmann, S., Albert, U-S., Budach, W., Follmann, M., Janni, W., Kopp, I., Kreienberg, R., Kühn, T., Langer, T., Nothacker, M., Scharl, A., Schreer, I., Link, H., Engel, J., Fehm, T., Weis, J., Welt, A., Steckelberg, A., Feyer, P., König, K., Hahne, A., Baumgartner, T., Kreipe, H. H., Knoefel, W. T., Denkinger, M., Brucker, S., Lüftner, D., Kubisch, C., Gerlach, C., Lebeau, A., Siedentopf, F., Petersen, C., Bartsch, H. H., Schulz-Wendtland, R., Hahn, M., Hanf, V., Müller-Schimpfle, M., Henscher, U., Roncarati, R., Katalinic, A., Heitmann, C., Honegger, C., Paradies, K., Bjelic-Radisic, V., Degenhardt, F., Wenz, F., Rick, O., Hölzel, D., Zaiss, M., Kemper, G., Budach, V., Denkert, C., Gerber, B., Tesch, H., Hirsmüller, S., Sinn, H-P., Dunst, J., Münstedt, K., Bick, U., Fallenberg, E., Tholen, R., Hung, R., Baumann, F., Beckmann, M. W., Blohmer, J., Fasching, P., Lux, M. P., Harbeck, N., Hadji, P., Hauner, H., Heywang-Köbrunner, S., Huober, J., Hübner, J., Jackisch, C., Loibl, S., Lück, H-J., von Minckwitz, G., Möbus, V., Müller, V., Nöthlings, U., Schmidt, M., Schmutzler, R., Schneeweiss, A., Schütz, F., Stickeler, E., Thomssen, C., Untch, M., Wesselmann, S., Bücker, A., Buck, A. & Stangl, S., 11.2018, In: GEBURTSH FRAUENHEILK. 78, 11, p. 1056-1088 33 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  3. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

    Wöckel, A., Festl, J., Stüber, T., Brust, K., Stangl, S., Heuschmann, P. U., Albert, U-S., Budach, W., Follmann, M., Janni, W., Kopp, I., Kreienberg, R., Kühn, T., Langer, T., Nothacker, M., Scharl, A., Schreer, I., Link, H., Engel, J., Fehm, T., Weis, J., Welt, A., Steckelberg, A., Feyer, P., König, K., Hahne, A., Kreipe, H. H., Knoefel, W. T., Denkinger, M., Brucker, S., Lüftner, D., Kubisch, C., Gerlach, C., Lebeau, A., Siedentopf, F., Petersen, C., Bartsch, H. H., Schulz-Wendtland, R., Hahn, M., Hanf, V., Müller-Schimpfle, M., Henscher, U., Roncarati, R., Katalinic, A., Heitmann, C., Honegger, C., Paradies, K., Bjelic-Radisic, V., Degenhardt, F., Wenz, F., Rick, O., Hölzel, D., Zaiss, M., Kemper, G., Budach, V., Denkert, C., Gerber, B., Tesch, H., Hirsmüller, S., Sinn, H-P., Dunst, J., Münstedt, K., Bick, U., Fallenberg, E., Tholen, R., Hung, R., Baumann, F., Beckmann, M. W., Blohmer, J., Fasching, P. A., Lux, M. P., Harbeck, N., Hadji, P., Hauner, H., Heywang-Köbrunner, S., Huober, J., Hübner, J., Jackisch, C., Loibl, S., Lück, H-J., von Minckwitz, G., Möbus, V., Müller, V., Nöthlings, U., Schmidt, M., Schmutzler, R., Schneeweiss, A., Schütz, F., Stickeler, E., Thomssen, C., Untch, M., Wesselmann, S., Bücker, A. & Krockenberger, M., 10.2018, In: GEBURTSH FRAUENHEILK. 78, 10, p. 927-948 22 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  4. 2016

  5. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

    Lebok, P., Roming, M., Kluth, M., Koop, C., Ozden, C., Taskin, B., Hussein, K., Lebeau, A., Witzel, I., Wölber, L., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Terracciano, L., Krech, R. H., von der Assen, A. & Burandt, E., 06.12.2016, In: ONCOTARGET. 7, 49, p. 81322-81331

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

    Lebok, P., Huber, J., Burandt, E-C., Lebeau, A., Marx, A. H., Terracciano, L., Heilenkötter, U., Jänicke, F., Müller, V., Paluchowski, P., Geist, S., Wilke, C., Simon, R., Sauter, G. & Quaas, A., 08.2016, In: MOL MED REP. 14, 2, p. 1443-50 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer

    Lebok, P., Öztürk, E., Heilenkötter, U., Jaenicke, F., Müller, V., Paluchowski, P., Geist, S., Wilke, C., Burandt, E., Lebeau, A., Wilczak, W., Krech, T., Simon, R., Sauter, G. & Quaas, A., 03.2016, In: ONCOL LETT. 11, 3, p. 1987-1994 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Cyclin D1 gene amplification is highly homogeneous in breast cancer

    Burandt, E., Grünert, M., Lebeau, A., Choschzick, M., Quaas, A., Jänicke, F., Müller, V., Scholz, U., Bokemeyer, C., Petersen, C., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G. & Wilczak, W., 01.2016, In: BREAST CANCER-TOKYO. 23, 1, p. 111-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2015

  10. 8p deletion is strongly linked to poor prognosis in breast cancer

    Lebok, P., Mittenzwei, A., Kluth, M., Özden, C., Taskin, B., Hussein, K., Möller, K., Hartmann, A., Lebeau, A., Witzel, I., Mahner, S., Wölber, L., Jänicke, F., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G., Terracciano, L., Krech, R., von der Assen, A., Müller, V. & Burandt, E., 2015, In: CANCER BIOL THER. 16, 7, p. 1080-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Partial PTEN deletion is linked to poor prognosis in breast cancer

    Lebok, P., Kopperschmidt, V., Kluth, M., Hube-Magg, C., Özden, C., Taskin, B., Hussein, K., Mittenzwei, A., Lebeau, A., Witzel, I., Wölber, L., Mahner, S., Jänicke, F., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, R., Sauter, G., Terracciano, L., Krech, R., von der Assen, A., Müller, V. & Burandt, E., 2015, In: BMC CANCER. 15, 1, p. 963

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2014

  13. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

    Burandt, E., Bari Noubar, T., Lebeau, A., Minner, S., Burdelski, C., Jänicke, F., Müller, V., Terracciano, L., Simon, R., Sauter, G., Wilczak, W. & Lebok, P., 01.12.2014, In: ONCOL REP. 32, 6, p. 2628-34 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Schnell wachsender Mammatumor der Stillphase

    Pöhler, M., Hanslik, M., Nemitz, S., Bürrig, K-F., Mentzel, T. & Lebeau, A., 13.09.2014, In: GYNAKOLOGE. 47, 11, p. 879-884

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Invasive Mammakarzinome: Die aktuelle WHO-Klassifikation

    Lebeau, A., Kriegsmann, M., Burandt, E. & Sinn, H-P., 01.02.2014, In: PATHOLOGE. 35, 1, p. 7-17 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Mammographie-Screening. Ist was dran an der Kritik?

    Lebeau, A., Heywang-Köbrunner, S. H. & Katalinic, A., 2014, In: patho.. 3, p. 6-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Transfer

  17. 2013

  18. Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility

    Sinn, P., Aulmann, S., Wirtz, R., Schott, S., Marmé, F., Varga, Z., Lebeau, A., Kreipe, H. & Schneeweiss, A., 01.09.2013, In: GEBURTSH FRAUENHEILK. 73, 9, p. 932-940 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

    Hoffmann, J., Souchon, R., Lebeau, A., Öhlschlegel, C., Gruber, G., Rageth, C., Weber, W., Harbeck, N., Janni, W., Kreipe, H., Fitzal, F., Resch, A., Bago-Horvath, Z., Peintinger, F. & AGO, 01.07.2013, In: EUR J CANCER. 49, 10, p. 2277-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. [Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].

    Lebeau, A., Kreipe, H., Dietel, M., Schlake, W. & Kreienberg, R., 2013, In: PATHOLOGE. 34, 4, p. 293-304 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

    Burandt, E. C., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G. & Lebeau, A., 2013, In: BREAST CANCER RES TR. 137, 3, p. 745-753 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

    Kuehn, T., Bauerfeind, I., Fehm, T., Fleige, B., Hausschild, M., Helms, G., Lebeau, A., Liedtke, C., von Minckwitz, G., Nekljudova, V., Schmatloch, S., Schrenk, P., Staebler, A. & Untch, M., 2013, In: LANCET ONCOL. 14, 7, p. 609-618 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2012

  24. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

    Grob, T., Heilenkötter, U., Geist, S., Paluchowski, P., Wilke, C., Jänicke, F., Quaas, A., Wilczak, W., Choschzick, M., Sauter, G. & Lebeau, A., 2012, In: BREAST CANCER RES TR. 134, 2, p. 561-567 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2011

  26. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

    Untch, M., Fasching, P. A., Konecny, G. E., Hasmüller, S., Lebeau, A., Kreienberg, R., Camara, O., Müller, V., Andreas, D. B., Kühn, T., Stickeler, E., Harbeck, N., Höss, C., Kahlert, S., Beck, T., Fett, W., Mehta, K. M., von Minckwitz, G. & Loibl, S., 2011, In: J CLIN ONCOL. 29, 25, p. 3351-3357 25.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

    Untch, M., Fasching, P. A., Konecny, G. E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1988-1998 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.

    Untch, M., von Minckwitz, G., Konecny, G. E., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M. W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P. A. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1999-2006 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 2010

  30. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

    Choschzick, M., Lassen, P., Lebeau, A., Marx, A., Terracciano, L., Heilenkötter, U., Jänicke, F., Bokemeyer, C., Izbicki, J. R., Sauter, G. & Simon, R., 2010, In: MODERN PATHOL. 23, 4, p. 603-610 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

    Schwarz, J., Tiling, R., Avril-Sassen, S., Mahner, S., Lebeau, A., Weber, C., Schwaiger, M., Jänicke, F., Untch, M. & Avril, N., 2010, In: BRIT J CANCER. 102, 1, p. 35-41 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.

    Choschzick, M., Bacher, U., Ayuketang Ayuk, F. & Lebeau, A., 2010, In: J CLIN PATHOL. 63, 6, p. 558-561 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. PPFIA1 and CCND1 are frequently coamplified in breast cancer.

    Dancau, A. M., Wuth, L., Waschow, M., Holst, F., Krohn, A., Choschzick, M., Terracciano, L., Politis, S., Kurtz, S., Lebeau, A., Friedrichs, K., Wenke, K., Monni, O. & Simon, R., 2010, In: GENE CHROMOSOME CANC. 49, 1, p. 1-8 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

    Lebeau, A., Turzynski, A., Braun, S., Behrhof, W., Fleige, B., Schmitt, W. D., Grob, T., Burkhardt, L., Hölzel, D., Jackisch, C., Thomssen, C., Müller, V. & Untch, M., 2010, In: J CLIN ONCOL. 28, 20, p. 3264-3270 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2009

  36. 2008 update of the guideline: early detection of breast cancer in Germany.

    Albert, U-S., Altland, H., Duda, V., Engel, J., Geraedts, M., Heywang-Köbrunner, S., Hölzel, D., Kalbheim, E., Koller, M., König, K., Kreienberg, R., Kühn, T., Lebeau, A., Nass-Griegoleit, I., Schlake, W., Schmutzler, R., Schreer, I., Schulte, H., Schulz-Wendtland, R., Wagner, U. & Kopp, I., 2009, In: J CANCER RES CLIN. 135, 3, p. 339-354 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Gene amplification in ductal carcinoma in situ of the breast.

    Burkhardt, L., Grob, T., Hermann, I., Burandt, E. C., Choschzick, M., Jänicke, F., Müller, V., Bokemeyer, C., Simon, R., Sauter, G., Wilczak, W. & Lebeau, A., 2009, In: BREAST CANCER RES TR.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

    Untch, M., Möbus, V., Kuhn, W., Muck, B. R., Thomssen, C., Bauerfeind, I., Harbeck, N., Werner, C., Lebeau, A., Schneeweiss, A., Kahlert, S., von Koch, F., Petry, K. U., Wallwiener, D., Kreienberg, R., Albert, U-S., Lück, H-J., Hinke, A., Jänicke, F. & Konecny, G. E., 2009, In: J CLIN ONCOL. 27, 18, p. 2938-2945 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

    Schwarz-Dose, J., Untch, M., Tiling, R., Sassen, S., Mahner, S., Kahlert, S., Harbeck, N., Lebeau, A., Brenner, W., Schwaiger, M., Jänicke, F. & Avril, N., 2009, In: J CLIN ONCOL. 27, 4, p. 535-541 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.

    Choschzick, M., Lebeau, A., Marx, A., Tharun, L., Terracciano, L., Heilenkötter, U., Jänicke, F., Bokemeyer, C., Simon, R., Sauter, G. & Schwarz, J., 2009, In: HUM PATHOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2008

  42. Estrogen receptor gene amplification occurs rarely in ovarian cancer.

    Issa, R., Lebeau, A., Grob, T., Holst, F., Moch, H., Terracciano, L., Choschzick, M., Sauter, G. & Simon, R., 2008, In: MODERN PATHOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. [Guideline for the Early Detection of Breast Cancer in Germany 2008. Recommendations from the short version]

    Albert, U-S., Altland, H., Duda, V., Engel, J., Geraedts, M., Heywang-Köbrunner, S., Hölzel, D., Kalbheim, E., Koller, M., König, K., Kreienberg, R., Kühn, T., Lebeau, A., Nass-Griegoleit, I., Schlake, W., Schmutzler, R., Schreer, I., Schulte, H., Schulz-Wendtland, R., Wagner, U. & Kopp, I., 2008, In: CHIRURG. 79, 6, p. 589-594 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): Results of a European consensus meeting.

    Heywang-Köbrunner, S. H., Sinnatamby, R., Lebeau, A., Lebrecht, A., Britton, P. D. & Schreer, I., 2008, In: EUR RADIOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. [Minutes of the working group on gynecopathology and breast pathology. On the occasion of the 92nd Annual Congress of the German Society for Pathology in Berlin]

    Lax, S., Lebeau, A. & Schneider, A., 2008, In: PATHOLOGE. 29, 2, p. 374-378 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.

    Lebeau, A., Grob, T., Holst, F., Seyedi-Fazlollahi, N., Moch, H., Terracciano, L., Turzynski, A., Choschzick, M., Sauter, G. & Simon, R., 2008, In: J PATHOL. 216, 2, p. 151-157 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. [Results of reference pathology in mammography screening]

    Kreipe, H. H., Höfler, H., Lebeau, A., Pickartz, H. & Schmidt, D., 2008, In: PATHOLOGE. 29, 2, p. 178-180 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. [Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008]

    Albert, U-S., Altland, H., Duda, V., Engel, J., Geraedts, M., Heywang-Köbrunner, S., Hölzel, D., Kalbheim, E., Koller, M., König, K., Kreienberg, R., Kühn, T., Lebeau, A., Nass-Griegoleit, I., Schlake, W., Schmutzler, R., Schreer, I., Schulte, H., Schulz-Wendtland, R., Wagner, U. & Kopp, I., 2008, In: ROFO-FORTSCHR RONTG. 180, 5, p. 455-465 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. 2007

  50. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

    Holst, F., Stahl, P., Ruiz, C., Hellwinkel, O., Jehan, Z., Wendland, M., Lebeau, A., Terracciano, L., Al-Kuraya, K., Jänicke, F., Sauter, G. & Simon, R., 2007, In: NAT GENET. 39, 5, p. 655-660 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.

    Lang, S., Tiwari, S., Andratschke, M., Loehr, I., Lauffer, L., Bergmann, C., Mack, B., Lebeau, A., Moosmann, A., Whiteside, T. L. & Zeidler, R., 2007, In: CANCER IMMUNOL IMMUN. 56, 10, p. 1645-1652 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. The risk of non-sentinel metastases in primary breast cancer.

    Bauerfeind, I. G., Kahlert, S., Himsl, I., Sorokina, Y., Ruehl, I. M., Lebeau, A., Linke, R., Untch, M. & Friese, K., 2007, In: ANTICANCER RES. 27, 4, p. 1929-1932 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. 2006

  54. Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection.

    Engel, J., Lebeau, A., Sauer, H. & Hölzel, D., 2006, In: BREAST. 15, 3, p. 452-455 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. [Experiences of the Bavarian mammography screening program]

    Nährig, J., Höfler, H., Heywang-Köbrunner, S. H., Prat, N., Hölzel, D., Wünsch, P. H. & Lebeau, A., 2006, In: PATHOLOGE. 27, 5, p. 387-391 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. [Herceptin therapy in breast cancer: new indication?]

    Lebeau, A., 2006, In: Verh Dtsch Ges Pathol. 90, p. 99-106

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. HgCl2 challenge in Brown Norway rats lead to dermatitis instead of arthritis.

    Schümann, K., Lebeau, A., Ettle, T. & Adam, O., 2006, In: RHEUMATOL INT. 26, 5, p. 393-395 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. [Isolated focus of the breast]

    Kotsianos, D., Lebeau, A. & Reiser, M., 2006, In: RADIOLOGE. 46, 9, p. 798-799, 801-802 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. [Prognostic factors in ductal carcinoma in situ]

    Lebeau, A., 2006, In: PATHOLOGE. 27, 5, p. 326-336 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

    Kaufmann, M., Hortobagyi, G. N., Goldhirsch, A., Scholl, S., Makris, A., Valagussa, P., Blohmer, J-U., Eiermann, W., Jackesz, R., Jonat, W., Lebeau, A., Loibl, S., Miller, W., Seeber, S., Semiglazov, V., Smith, R., Souchon, R., Stearns, V., Untch, M. & von Minckwitz, G., 2006, In: J CLIN ONCOL. 24, 12, p. 1940-1949 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review